Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Atossa Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 90 | 1 | 93 | +4 |
| Shares | 35.7M | 500 | 31.1M | −4.66M (−13.0%) |
| Value | $225.8M | $3.00K | $102.1M | −$123.7M (−54.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Atossa Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 1,021,707 | $3.33M | 0.00% |
| D. E. Shaw & Co., Inc. | 896,057 | $2.92M | 0.00% |
| HRT Financial LP | 243,504 | $793.0K | 0.00% |
| Mirabella Financial Services LLP | 216,320 | $705.0K | 0.09% |
| ExodusPoint Capital Management, LP | 139,989 | $456.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 94,950 | $310.0K | 0.01% |
| SG Americas Securities, LLC | 82,160 | $268.0K | 0.00% |
| UBS Group AG | 40,665 | $133.0K | 0.00% |
| AQR Capital Management LLC | 33,186 | $108.0K | 0.00% |
| Newbridge Financial Services Group, Inc. | 32,000 | $104.0K | 0.07% |
| HighTower Advisors, LLC | 20,100 | $65.0K | 0.00% |
| Franklin Resources Inc | 14,300 | $47.0K | 0.00% |
| Private Advisor Group, LLC | 11,205 | $37.0K | 0.00% |
| First Republic Investment Management, Inc. | 11,000 | $36.0K | 0.00% |
| Kestra Advisory Services, LLC | 10,500 | $34.0K | 0.00% |
| Sphinx Trading, LP | 1,900 | $6.00K | 0.01% |
| Signaturefd, LLC | 300 | $1.00K | 0.00% |
| Hudock, Inc. | 500 | $1.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 83 | $0 | 0.00% |
| Ellevest, Inc. | 88 | $0 | 0.00% |
Sold out (16)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Group One Trading, L.P. | 1,644,488 | $10.4M |
| Sabby Management, LLC | 1,045,987 | $6.61M |
| Voloridge Investment Management, LLC | 255,984 | $1.62M |
| Squarepoint Ops LLC | 188,259 | $1.19M |
| Enlightenment Research, LLC | 73,100 | $462.0K |
| Cutler Group LP | 72,179 | $456.0K |
| DC Investments Management, LLC | 64,490 | $408.0K |
| DuPont Capital Management Corp | 35,145 | $222.0K |
| Gotham Asset Management, LLC | 22,376 | $141.0K |
| Point72 Hong Kong Ltd | 10,224 | $65.0K |
| SG3 Management, LLC | 2,500 | $16.0K |
| CenterStar Asset Management, LLC | – | $10.0K |
| Wells Fargo & Company | 1,164 | $7.00K |
| Federated Hermes, Inc. | 138 | $1.00K |
| Salem Investment Counselors Inc | 3 | $0 |
| Eaton Vance Management | 5 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Castleview Partners, LLC | 500 | $3.00K |